Kanneboyina Nagaraju

Kanneboyina Nagaraju is a medical scientist and immunologist who is credited with creating the MHC Class I transgenic mouse model for autoimmune myositis.[1] Nagaraju is also credited with identifying novel glucocorticoid analogs with reduced side effect profiles in collaboration with Eric Hoffman and John McCall.[2] He led international efforts to improve rigor and reproducibility of preclinical drug trials and phenotyping in neuromuscular disease models.[3][4][5]

Kanneboyina Nagaraju
Born
India
TitleProfessor
Academic background
EducationSri Venkateswara Veterinary University

Indian Veterinary Research Institute

Sanjay Gandhi Postgraduate Institute of Medical Sciences
Academic work
InstitutionsNational Institute of Health

Johns Hopkins University School of Medicine Children's National Medical Center

George Washington University School of Medicine
Binghamton University

After receiving veterinary training at the Sri Venkateswara Veterinary University and the Indian Veterinary Research Institute, he attended the Sanjay Gandhi Postgraduate Institute of Medical Sciences where he received his PhD in Immunology and completed his post-doctoral training at NIH. Nagaraju was a tenure-track faculty member at the Johns Hopkins University School of Medicine and a tenured professor at Children's National Medical Center[6] and George Washington University School of Medicine.[7] He currently serves as Professor and Founding Chair of Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, SUNY-Binghamton University.[8] He is Co-Founder, President, CEO of AGADA Biosciences[9] and Co-Founder, Vice President of Research at ReveraGen BioPharma.[10]

References
  1. Nagaraju, K.; Raben, N.; Loeffler, L.; Parker, T.; Rochon, P. J.; Lee, E.; Danning, C.; Wada, R.; Thompson, C. (1 August 2000). "Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies". Proceedings of the National Academy of Sciences of the United States of America. 97 (16): 9209–9214. doi:10.1073/pnas.97.16.9209. ISSN 0027-8424. PMC 16847. PMID 10922072.
  2. Heier, Christopher R.; Damsker, Jesse M.; Yu, Qing; Dillingham, Blythe C.; Huynh, Tony; Van der Meulen, Jack H.; Sali, Arpana; Miller, Brittany K.; Phadke, Aditi (October 2013). "VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects". EMBO Molecular Medicine. 5 (10): 1569–1585. doi:10.1002/emmm.201302621. ISSN 1757-4684. PMC 3799580. PMID 24014378.
  3. Willmann, Raffaella; De Luca, Annamaria; Benatar, Michael; Grounds, Miranda; Dubach, Judith; Raymackers, Jean-Marc; Nagaraju, Kanneboyina; TREAT-NMD Neuromuscular Network (January 2012). "Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice". Neuromuscular Disorders. 22 (1): 43–49. doi:10.1016/j.nmd.2011.04.012. ISSN 1873-2364. PMC 3227750. PMID 21737275.
  4. Willmann, Raffaella; Luca, Annamaria De; Nagaraju, Kanneboyina; Rüegg, Markus A. (14 May 2015). "Best Practices and Standard Protocols as a Tool to Enhance Translation for Neuromuscular Disorders" (PDF). Journal of Neuromuscular Diseases. 2 (2): 113–117. doi:10.3233/jnd-140067. ISSN 2214-3599. PMID 27858730.
  5. Gordish-Dressman, Heather; Willmann, Raffaella; Dalle Pazze, Laura; Kreibich, Arati; van Putten, Maaike; Heydemann, Ahlke; Bogdanik, Laurent; Lutz, Cathleen; Davies, Kay (2018). ""Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic". Journal of Neuromuscular Diseases. 5 (4): 407–417. doi:10.3233/JND-180324. ISSN 2214-3599. PMC 6218134. PMID 30198876.
  6. "Center for Genetic Medicine Research". Children’s Research Institute Academic Annual Report 2017-2018. Retrieved 24 December 2018.
  7. "Faculty Directory | the School of Medicine & Health Sciences | the George Washington University".
  8. Pharmacy, Kanneboyina Nagaraju Professor; Founding Chair School of. "Kanneboyina Nagaraju - Faculty and Staff - School of Pharmacy and Pharmaceutical Sciences | Binghamton University". School of Pharmacy and Pharmaceutical Sciences - Binghamton University. Retrieved 10 December 2018.
  9. "Home". AGADA Biosciences. Retrieved 24 December 2018.
  10. "Home". ReveraGen BioPharma. Retrieved 24 December 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.